Du J - Search Results

1

MicroRNA-451 regulates activating transcription factor 2 expression and inhibits liver cancer cell migration.

Lv G, Hu Z, Tie Y, Du J, Fu H, Gao X, Zheng X. Lv G, et al. Among authors: du j. Oncol Rep. 2014 Sep;32(3):1021-8. doi: 10.3892/or.2014.3296. Epub 2014 Jun 27. Oncol Rep. 2014. PMID: 24968707

2

[Clinicopathologic features of hepatocellular carcinoma: an analysis of 185 cases].

Wang YL, Du JL, Shi HY, Guo AT, Wei LX. Wang YL, et al. Zhonghua Zhong Liu Za Zhi. 2010 Aug;32(8):609-13. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21122415 Chinese.

3

The tumor suppressor role of Src homology phosphotyrosine phosphatase 2 in hepatocellular carcinoma.

Jiang C, Hu F, Tai Y, Du J, Mao B, Yuan Z, Wang Y, Wei L. Jiang C, et al. Among authors: du j. J Cancer Res Clin Oncol. 2012 Apr;138(4):637-46. doi: 10.1007/s00432-011-1143-5. Epub 2012 Jan 7. J Cancer Res Clin Oncol. 2012. PMID: 22228034

4

Increased CDC20 expression is associated with development and progression of hepatocellular carcinoma.

Li J, Gao JZ, Du JL, Huang ZX, Wei LX. Li J, et al. Among authors: du jl. Int J Oncol. 2014 Oct;45(4):1547-55. doi: 10.3892/ijo.2014.2559. Epub 2014 Jul 24. Int J Oncol. 2014. PMID: 25069850

5

miR-320a regulates high mobility group box 1 expression and inhibits invasion and metastasis in hepatocellular carcinoma.

Lv G, Wu M, Wang M, Jiang X, Du J, Zhang K, Li D, Ma N, Peng Y, Wang L, Zhou L, Zhao W, Jiao Y, Gao X, Hu Z. Lv G, et al. Among authors: du j. Liver Int. 2017 Sep;37(9):1354-1364. doi: 10.1111/liv.13424. Epub 2017 Apr 11. Liver Int. 2017. PMID: 28317284

6

[Expression and clinicopathologic significance of GPC3 and other antibodies in well-differentiated hepatocellular carcinoma].

DU JL, Wei LX, Wang YL. DU JL, et al. Zhonghua Bing Li Xue Za Zhi. 2011 Jan;40(1):11-6. Zhonghua Bing Li Xue Za Zhi. 2011. PMID: 21429352 Chinese.

7

[Expression of glypican-3, hepatocyte antigen, alpha-fetoprotein, CD34 and CD10 in hepatocellular carcinoma: a clinicopathologic analysis of 375 cases].

Du JL, Wang YL, Shi HY, Guo AT, Wei LX. Du JL, et al. Zhonghua Bing Li Xue Za Zhi. 2012 May;41(5):309-13. doi: 10.3760/cma.j.issn.0529-5807.2012.05.006. Zhonghua Bing Li Xue Za Zhi. 2012. PMID: 22883669 Chinese.

8

Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.

Li J, Gao JZ, Du JL, Wei LX. Li J, et al. Among authors: du jl. World J Gastroenterol. 2014 May 28;20(20):6336-44. doi: 10.3748/wjg.v20.i20.6336. World J Gastroenterol. 2014. PMID: 24876756 Free PMC article.

9

[Study on the morphological features, pathologic diagnosis and differential diagnosis of well-differentiated hepatocellular carcinoma].

Wei L, Du J, Wang Y, Shi H, Zhao J. Wei L, et al. Among authors: du j. Zhonghua Bing Li Xue Za Zhi. 2014 Jul;43(7):459-62. Zhonghua Bing Li Xue Za Zhi. 2014. PMID: 25327795 Chinese.

10

Long non-coding RNA HOTAIR is a marker for hepatocellular carcinoma progression and tumor recurrence.

Gao JZ, Li J, DU JL, Li XL. Gao JZ, et al. Among authors: du jl. Oncol Lett. 2016 Mar;11(3):1791-1798. doi: 10.3892/ol.2016.4130. Epub 2016 Jan 19. Oncol Lett. 2016. PMID: 26998078 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,749 results

Search Page

Filters